Results 251 to 260 of about 12,411,445 (303)
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić +4 more
wiley +1 more source
Editorial: Public health outcomes: the role of social security systems in improving residents' health welfare. [PDF]
Ma C, Li D.
europepmc +1 more source
A Qualitative Study on Self-Perceived Burden in Elderly Patients with Diabetes and Frailty Based on Social Ecological Theory. [PDF]
Chen M +5 more
europepmc +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Socioeconomic differences in return to work after oncological rehabilitation: An analysis using data from German Pension Insurance. [PDF]
Nowossadeck E +4 more
europepmc +1 more source
How Do Poverty, Insurance, and Government Assistance Impact Diabetic Foot Ulcer Outcomes? A Scoping Review. [PDF]
LaMantia JN +10 more
europepmc +1 more source
Social disparities, navigational health literacy, and unmet needs in Germany: results of a population survey. [PDF]
Ulrich TW, Klein J, von dem Knesebeck O.
europepmc +1 more source
Welfare Regimes and Out-of-Pocket Healthcare Spending in the Last Year of Life Among Cancer Decedents in Europe and Israel. [PDF]
Tur-Sinai A, Bentur N.
europepmc +1 more source

